Navigation Links
Varian Medical Systems Reports Results for Fourth Quarter of Fiscal Year 2013
Date:10/23/2013

k
"We remain confident and committed to executing on our strategic initiatives – global growth, innovation, software and service, commercializing protons and operational excellence.  Our product line and global presence has never been stronger," said Wilson.  "The company is driving for continued growth in all of our businesses during fiscal year 2014."For the first quarter of fiscal year 2014, we expect revenues to grow by 6 to 7 percent and earnings per diluted share to be in the range of $0.87 to $0.91.  For fiscal year 2014, we expect revenues to grow in the range of 6 to 8 percent and earnings per diluted share to be in the range of $4.22 to $4.34."

Investor Conference Call
Varian Medical Systems is scheduled to conduct its fourth quarter fiscal year 2013 conference call at 2 p.m. PT today.  To hear a live webcast or replay of the call, visit the investor relations page on the company's web site at www.varian.com/investor where it will be archived for a year.  To access the call via telephone, dial 1-877-869-3847 from inside the U.S. or 1-201-689-8261 from outside the U.S.  The replay can be accessed by dialing 1 877-660-6853 from inside the U.S or 1-201-612-7415 from outside the U.S. and entering confirmation code 422052.  The telephone replay will be available through 5 p.m. PT, Friday, October 25, 2013.

For automatic "e-mail alerts" regarding Varian news, events, and new investor materials on the website, investors can subscribe on the company website: http://varian.investorroom.com/index.php?s=58. For additional information, contact investor relations at 1 650 424-5834.

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachythe
'/>"/>

SOURCE Varian Medical Systems
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Varian Medical Systems Schedules Fiscal Year End Review for Investors in New York
2. Varians Calypso Tumor Tracking System Used in Lung, Stomach and Prostate Cancer Treatments at Leading European Cancer Center
3. Varian and Siemens to Showcase Collaborative Offerings at 2013 ASTRO Meeting in Atlanta
4. CIVCOs Protura and Varian Integration Keeps Motion Management Clearly on Target at ASTRO 2013
5. Varian Medical Systems Publishes 2013 Sustainability Report Outlining Environmental, Charitable, Safety and Health Access Achievements
6. Varian Medical Systems Schedules Investor Meeting at ASTRO in Atlanta
7. The Majority of Surveyed Oncologists Prescribe Avastin Off-label to Their Ovarian Cancer Patients; However Approximately Half Encounter Access and Reimbursement Hurdles
8. Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2013
9. Supreme Court Ruling Today Allows DNATraits to Offer Low Cost BRCA Breast and Ovarian Cancer Gene Testing in U.S.
10. Varian Software Successfully Connected with Siemens Linear Accelerators
11. Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... HILL, N.C. , July 11, 2014 /PRNewswire/ ... analysis approaches are evolving across industry sectors to ... now examining better ways to engage with and ... consumers inform themselves and make critical purchasing decisions. ... benchmarking firm, Best Practices, LLC, one area where ...
(Date:7/11/2014)... Research and Markets  has announced the ... report to their offering. ... a hollow needle commonly used with a syringe to ... fluids from it. A hypodermic needle is used for ... cannot be ingested. Hypodermic needles are broadly classified into ...
(Date:7/11/2014)... July 11, 2014 According to ... "Endoscopy Devices Market (Endoscopes, Endoscopic Operative Devices, and Visualization ... and Forecast, 2013-2019" the global endoscopy devices market was ... expected to grow at a CAGR of 6.8% from ... USD 36.9 billion in 2019. Browse the ...
Breaking Medicine Technology:New Technologies Transforming Consumer Marketing Research Playbook 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 2Global Hypodermic Needles Market 2014-2018: Key Vendors are Becton, Dickinson and Co, Covidien, Retractable Technologies and Terumo Corp. 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6
(Date:7/14/2014)... 13, 2014 (HealthDay News) -- Eye tests could be ... Alzheimer,s disease, two new studies suggest. In one ... certain eye test found a significant association between levels ... and levels of the plaques in the brain. Beta-amyloid ... This type of eye test could be used ...
(Date:7/14/2014)... MONDAY, July 14, 2014 (HealthDay News) -- Being physically ... risk for Alzheimer,s disease and other types of dementia, ... our studies, we found that physical exercise at various ... Dr. Yonas Geda from the Mayo Clinic, said in ... results, but they are not yet conclusive. More research ...
(Date:7/14/2014)... HealthDay Reporter MONDAY, July 14, 2014 ... multiple health issues, but dementia isn,t one of them, according ... even delay dementia, the researchers found. "For those who ... with a later age of developing full-blown dementia compared to ... Woodruff, an assistant professor of neurology at the ...
(Date:7/14/2014)... 14, 2014 Follow ... liquid chromatography or UPLC is a new ... chromatography that involves the use of extremely ... separate chromatographic compounds. This highly sensitive qualitative ... and analysis of chromatography samples. UPLC functions ...
(Date:7/14/2014)... Clara, California (PRWEB) July 14, 2014 ... America for the 6th Annual 5K run and one-mile ... America, winds through the park attractions, and finishes inside ... event has raised over $150,000 for the Mission City ... throughout Santa Clara County. , Seasoned athletes, part-time ...
Breaking Medicine News(10 mins):Health News:Eye Tests Might Help ID Alzheimer's, Studies Suggest 2Health News:Staying Active May Help Prevent Dementia 2Health News:Widowhood May Delay Dementia in Some Seniors, Study Finds 2Health News:Widowhood May Delay Dementia in Some Seniors, Study Finds 3Health News:Need for Faster Sample Analysis Drives Demand for UPLC, According to New Trend Report Published by Global Industry Analysts, Inc. 2
... on its services for individuals living with autism, and sharing the results ... the services and supports that families living with autism desperately need. ... ... shining the spotlight on its services for individuals living with autism, and ...
... the Family" with Allen Cardoza , Los Angeles, ... ANGELES, April 2 Our special guest this week ... successful private practice. Shelly has been a coach and ... corporate organizations as a Doctor of Psychology and a ...
... how a small hospital improved charge capture performance, ... using Craneware,s Bill AnalyzerATLANTA, April 2 Craneware, ... of financial performance solutions, announced today it will ... at the annual conference of the Healthcare Information ...
... The following is a statement from Jeff Levi, PhD, ... to the release of the new report Beyond Health ... Wood Johnson Foundation Commission to Build a Healthier America:"Every American ... or she can be. And every community should be ...
... Take Place on May 2; ... on May 9 LOS ANGELES, April 2 Revlon (NYSE: REV ... Jennifer Connelly and Jessica Alba along with NBC late night host ... in New York taking place on Saturday, May 2, 2009 , while ...
... with the glitazone class of diabetes drugs leads to ... edema (DME)a common complication that can lead to vision ... the American Journal of Ophthalmology ( http://www.elsevier.com/locate/ajo ... about 170,000 patients with diabetes, Drs. Donald S. Fong ...
Cached Medicine News:Health News:Easter Seals Celebrates World Autism Awareness Day, Hosting Series of Community Forums to Identify Needed Services and Supports for Families 2Health News:Easter Seals Celebrates World Autism Awareness Day, Hosting Series of Community Forums to Identify Needed Services and Supports for Families 3Health News:Easter Seals Celebrates World Autism Awareness Day, Hosting Series of Community Forums to Identify Needed Services and Supports for Families 4Health News:Easter Seals Celebrates World Autism Awareness Day, Hosting Series of Community Forums to Identify Needed Services and Supports for Families 5Health News:Craneware and St. Joseph to Present Revenue Enhancement Success Story at HIMSS 2Health News:Trust for America's Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America 2Health News:Trust for America's Health Supports Recommendations from Robert Wood Johnson Foundation Commission to Build a Healthier America 3Health News:Jessica Alba, Christina Applegate, Jennifer Connelly, Miley Cyrus & Jimmy Fallon on Board to Host Entertainment Industry Foundation's 2009 Revlon Run/Walk 2Health News:Jessica Alba, Christina Applegate, Jennifer Connelly, Miley Cyrus & Jimmy Fallon on Board to Host Entertainment Industry Foundation's 2009 Revlon Run/Walk 3Health News:Jessica Alba, Christina Applegate, Jennifer Connelly, Miley Cyrus & Jimmy Fallon on Board to Host Entertainment Industry Foundation's 2009 Revlon Run/Walk 4Health News:Diabetes drug class linked to vision-threatening complication 2
... a low osmolar ionic dimer. Each ... meglumine, 196 mg of ioxaglate sodium ... disodium as a stabilizer. The solution ... each milliliter and provides 32% (320 ...
... IMAGOPAQUE is a non-ionic monomeric contrast ... in adults and children. After a decade ... 3.5 million examinations, IMAGOPAQUE has proven to ... effort in hundreds of radiology departments.Results from ...
... is a liver-specific contrast agent approved for ... Its introduction expands the Amersham Health portfolio ... injected intravenously, TESLASCAN aids in the detection, ... Imaging can begin within minutes of injection, ...
... a new Contrast Agent for ... of stabilized SF6 microbubbles. The ... between 1 and 10 m, ... 2 and 5 x 108 ...
Medicine Products: